What is the management approach for a 21-year-old male patient with a grade 3 splenic hematoma (12x10x3cm), who is hemodynamically stable, has a hemoglobin level of 12.6, controlled pain, and fluid around the spleen and in the pelvis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Grade 3 Splenic Hematoma in a Hemodynamically Stable 21-Year-Old Male

This patient should be managed with non-operative management (NOM) as first-line treatment, with strong consideration for prophylactic angioembolization given the large hematoma size (12x10x3cm) and presence of free fluid, requiring ICU admission for continuous monitoring for at least 24-48 hours. 1, 2, 3

Classification and Risk Stratification

Your patient has a WSES Class II injury (hemodynamically stable AAST-OIS grade III), which is classified as a moderate splenic injury. 1 The 12x10x3cm intraparenchymal hematoma exceeds the 5cm threshold that defines grade III injury, and the presence of perisplenic and pelvic fluid indicates significant hemorrhage. 1, 3

Immediate Management Protocol

Admission and Monitoring Requirements

  • Admit to ICU for continuous monitoring for at least the first 24 hours, with capability for immediate conversion to emergency laparotomy if needed. 1, 2, 3
  • This management approach is only appropriate in facilities with 24/7 access to emergency operating room, interventional radiology, trained surgeons, and immediate blood product availability. 1, 2
  • Maintain bed rest for 48-72 hours with serial clinical examinations and laboratory monitoring (hemoglobin/hematocrit every 6-8 hours initially). 1, 2, 3

Angioembolization Decision

Strongly consider prophylactic angioembolization even without CT contrast blush, as this is a large grade III injury with significant free fluid. 1, 2, 3 The evidence shows:

  • Angioembolization should be considered first-line intervention in hemodynamically stable patients with grade III injuries, regardless of contrast blush presence. 1, 3
  • For grade III injuries specifically, angioembolization reduces NOM failure rates and significantly shortens hospital length of stay (7.2 vs 10.8 days). 4
  • Use coils rather than temporary agents when performing angioembolization. 3

Blood Product Management

With hemoglobin of 12.6 g/dL, immediate transfusion is not required, but maintain close monitoring. 2 Transfusion becomes indicated if:

  • Hemoglobin drops below 7-8 g/dL with hemodynamic stability
  • Any signs of hemodynamic instability develop
  • Evidence of ongoing bleeding with declining hematocrit 2

Criteria for Conversion to Operative Management

Proceed immediately to splenectomy if any of the following develop: 1, 2, 3

  • Hemodynamic instability despite resuscitation (systolic BP <90 mmHg with vasoconstriction, altered consciousness, or requiring vasopressors)
  • Transfusion requirement exceeding 40 mL/kg (approximately 4-6 units) within 24 hours without hemodynamic stabilization
  • Significant ongoing drop in hematocrit requiring continuous transfusions
  • Development of peritonitis
  • Failed angioembolization with continued bleeding

Risk Factors Requiring Heightened Vigilance

While your patient is young (21 years old), the following factors warrant intensive monitoring: 1, 3, 5

  • Large hematoma size (>5cm) - this 12x10x3cm hematoma significantly increases risk
  • Presence of free fluid in pelvis and around spleen
  • Grade III injury has intermediate risk for NOM failure

The overall NOM success rate for grade III injuries is approximately 85-90%, but can approach 100% with appropriate use of angioembolization. 3, 4

Thromboprophylaxis

  • Initiate mechanical prophylaxis immediately (sequential compression devices) - this is safe and recommended. 2
  • Consider LMWH-based prophylaxis starting 24-48 hours after injury if hemodynamically stable and no evidence of ongoing bleeding. 2
  • Splenic trauma without active bleeding is not an absolute contraindication to pharmacologic VTE prophylaxis. 2

Follow-Up Imaging and Activity Restrictions

  • Repeat CT scan is indicated if there is declining hematocrit, clinical deterioration, or to evaluate for vascular complications (pseudoaneurysm, arteriovenous fistula). 1, 3
  • Hospital stay should be minimum 3-5 days for this grade III injury with large hematoma. 6
  • Restrict activity for 6 weeks after discharge before resuming normal activities, as delayed splenic rupture risk is highest in first 3 weeks (0.2-0.3% incidence). 1, 3

Common Pitfalls to Avoid

  • Do not discharge prematurely - the presence of significant free fluid and large hematoma size requires extended observation beyond the typical 2-3 days for lower grade injuries. 1, 3
  • Do not assume hemodynamic stability will persist - approximately 27% of patients initially managed non-operatively require intervention within 30 days, with arterial complications being key risk factors. 5
  • Do not delay angioembolization if any vascular abnormality is identified on CT or if clinical deterioration occurs. 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Splenic Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Grade 3 Splenic Laceration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Grade 5 Splenic Injury in a Hemodynamically Stable Patient

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.